Skin Cancer Prevention: Current Research Frontiers and Public Health Strategies

Skin cancer (melanoma, BCC, SCC) is the most common cancer. Prevention targets UV exposure, early detection, and emerging biologic strategies.

1. Photoprotection Innovation

• Next-gen sunscreens: Broad-spectrum (UVA1/UVA2/UVB), photostable filters (bemotrizinol, bisoctrizole), DNA repair enzymes (photolyase, endonuclease), antioxidants (vitamin E, niacinamide, polypodium leucotomos).
• Textile UPF: Standardized UPF 50+ clothing, hats, swimwear – more reliable than sunscreen alone.
• Wearable UV sensors: Real-time dose monitoring (smartphone-linked).

2. Chemoprevention

• Nicotinamide (vitamin B3) 500 mg BID: ONTRAC trial – 23% ↓ new NMSC in high-risk. Safe, inexpensive.
• Retinoids (acitretin, isotretinoin): High-risk (transplant, XP) – teratogenicity, monitoring needed.
• COX-2 inhibitors, DFMO, polyphenols: Under investigation.

3. Early Detection Technologies

• Dermoscopy + AI: Algorithm-assisted diagnosis (sensitivity >90% for melanoma).
• Total body photography + sequential digital dermoscopy: Detects new/changing lesions in high-risk.
• Reflectance confocal microscopy (RCM): Non-invasive "optical biopsy" – cellular resolution.
• Blood biomarkers: ctDNA, miRNA, S100B for melanoma surveillance.

4. Immunoprevention

• HPV vaccine: Prevents SCC (anogenital, oropharyngeal).
• Melanoma vaccines (neoantigen, mRNA): Phase II/III trials (e.g., mRNA-4157 + pembrolizumab adjuvant).
• Checkpoint inhibitors (topical/systemic): Prevent progression of actinic keratosis → SCC.

5. Behavior Change & Policy

• School-based sun safety curricula, shade structures.
• Indoor tanning bans for minors (20+ countries, many US states).
• Mass media campaigns (Slip-Slop-Slap, UV index alerts).
• Occupational UV protection standards.

6. Nutrition & Microbiome

• Mediterranean diet, carotenoids, polyphenols, omega-3s – observational benefit.
• Gut-skin axis: microbiome modulation of UV immunity.

7. High-Risk Populations

• Organ transplant recipients (100× SCC risk) – rigorous surveillance, nicotinamide, sirolimus conversion.
• Xeroderma pigmentosum, Gorlin syndrome, CDKN2A carriers – specialized multidisciplinary care.

Prevention is multilayered: behavioral, technological, pharmacologic, immunologic. Integration into primary care maximizes reach.